Literature DB >> 6700722

Formation of the 3' end of histone mRNA by post-transcriptional processing.

P A Krieg, D A Melton.   

Abstract

The specific 3' termini of a number of eukaryotic mRNAs have been shown to be generated by the post-transcriptional processing of primary transcripts or pre-mRNAs. The sequence AAUAAA, present in the 3' region of nearly all eukaryotic mRNAs, appears to be involved in the cleavage and subsequent polyadenylation of the primary transcript. An exception to this general rule is the case of the histone mRNAs, which lack the AAUAAA sequence and are not normally polyadenylated. Histone mRNAs do, however, contain a highly conserved 23 base pair sequence at their 3' termini, which is required for correct 3' end formation. The similarity between this conserved sequence, which can be drawn as a hairpin loop, and bacterial transcription terminators has led several investigators to suggest that the specific 3' end of histone mRNA is formed by termination of transcription. So far, however, experimental results have not been presented which make it possible to distinguish between a post-transcriptional processing or a transcription termination mechanism for the formation of histone mRNA 3' termini. We have investigated this issue by synthesizing in vitro unprocessed histone pre-mRNAs that extend past the normal 3' terminus. These in vitro synthesized pre-mRNAS were injected into frog oocyte nuclei to study their fate. The results demonstrate that correct 3' ends of chicken histone H2B mRNAs can be formed by RNA processing of longer synthetic pre-mRNAs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6700722     DOI: 10.1038/308203a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  51 in total

Review 1.  Growth regulation of human variant histone genes and acetylation of the encoded proteins.

Authors:  D Alvelo-Ceron; L Niu; D G Collart
Journal:  Mol Biol Rep       Date:  2000-06       Impact factor: 2.316

2.  The inability of the Psammechinus miliaris H3 RNA to be processed in the Xenopus oocyte is associated with sequences distinct from those highly conserved amongst sea urchin histone RNAs.

Authors:  F Schaufele; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

3.  A Missense Mutation in the Extracellular Domain of αENaC Causes Liddle Syndrome.

Authors:  Mahdi Salih; Ivan Gautschi; Miguel X van Bemmelen; Michael Di Benedetto; Alice S Brooks; Dorien Lugtenberg; Laurent Schild; Ewout J Hoorn
Journal:  J Am Soc Nephrol       Date:  2017-07-14       Impact factor: 10.121

Review 4.  Formation of the 3' end of histone mRNA: getting closer to the end.

Authors:  Zbigniew Dominski; William F Marzluff
Journal:  Gene       Date:  2007-05-04       Impact factor: 3.688

5.  Isolation and characterization of a Xenopus laevis C protein cDNA: structure and expression of a heterogeneous nuclear ribonucleoprotein core protein.

Authors:  F Preugschat; B Wold
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  tRNA derived insertion element in histone gene repeating unit of Drosophila melanogaster.

Authors:  Y Matsuo; T Yamazaki
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

7.  Codon usage in histone gene families of higher eukaryotes reflects functional rather than phylogenetic relationships.

Authors:  D Wells; W Bains; L Kedes
Journal:  J Mol Evol       Date:  1986       Impact factor: 2.395

8.  Cloning and characterization of a core histone gene tandem repeat in Urechis caupo.

Authors:  L D Ingham; F C Davis
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

9.  A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure.

Authors:  E T Schenborn; R C Mierendorf
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

10.  Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.

Authors:  D H Lovett; A Larsen
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.